Endo posts first quarter beat, embraces branded drugs, injectables – Reuters

Endo posts first quarter beat, embraces branded drugs, injectables
Reuters
The company is also testing the drug's ability to reduce cellulite, a condition that causes dimpling of the skin especially on hips and thighs, and expects results from trials in the first quarter of 2019. In a bid to augment its sterile injectables

Read more: www.reuters.com

About the Author AdelinaDuh

Leave a Comment: